| Authors: |
Wrenn ED; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Harris JC; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Apfelbaum AA; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Valenti JR; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Lipson PA; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA.; School of Medicine, University of Washington, Seattle, WA, USA., Walter SI; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Garcia NM; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Miyaki A; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Chen SC; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA., Olson JM; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Price JS; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Bailey KM; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Lawlor ER; Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA. |
